XML 43 R35.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Convertible Preferred Stock, Common Stock and Stockholders' Equity (Deficit) - Additional Information (Details) - USD ($) |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Feb. 05, 2024 | Jan. 19, 2024 | Mar. 20, 2023 | May 31, 2024 | Aug. 31, 2023 | Oct. 31, 2022 | Nov. 30, 2020 | Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares authorized |  |  |  |  |  |  |  | 500,000,000 |  |  | 500,000,000 |  | 500,000,000
Preferred stock, shares authorized |  |  |  |  |  |  |  | 10,000,000 |  |  | 10,000,000 |  | 0
Available for sale under Shelf Registration Statement |  |  |  |  |  |  |  | $ 99,600,000 |  |  | $ 99,600,000 |  |
Net proceeds |  |  |  |  |  |  |  | $ 47,000 |  |  |  |  |
Common stock, shares issued |  |  |  |  |  |  |  | 10,750,156 |  |  | 10,750,156 |  | 5,754,505
Fair value of warrant liability |  |  |  |  |  |  |  |  |  |  | $ (7,890,000) | $ (1,146,000) |
Common stock par value |  |  |  |  |  |  |  | $ 0.0001 |  |  | $ 0.0001 |  | $ 0.0001
Expected term (years) |  |  |  |  |  |  |  |  |  |  | 6 years 29 days | 6 years 3 months |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  | 2.96% |  |
Expected volatility |  |  |  |  |  |  |  |  |  |  | 89.00% |  |
Expected dividend yield |  |  |  |  |  |  |  |  |  |  | 0.00% | 0.00% |
General and administrative |  |  |  |  |  |  |  | $ 2,372,000 |  | $ 2,769,000 | $ 5,195,000 | $ 18,618,000 |
Preferred stock, par value |  |  |  |  |  |  |  | $ 0.0001 |  |  | $ 0.0001 |  | $ 0.0001
Conversion of stock description |  | Each Placement Agent Warrant was accompanied by one Tranche A Common Warrant to purchase one half of a share of common stock and one Tranche B Warrant to purchase one half of a share of common stock, for an aggregate of 75,746 Common Warrants. |  |  |  |  |  |  |  |  |  |  |
2023 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from the private placement |  |  |  |  |  |  |  |  |  |  | $ 20,400,000 |  |
Stock issued |  |  |  |  |  |  |  |  |  |  | 20,700,000 |  |
Net proceeds |  |  |  |  |  |  |  |  |  |  | $ 10,300,000 |  |
2024 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  | $ 0.0001 |  |  |  |  |  | $ 3.827 |  |  | $ 3.827 |  |
Number of warrants converted to common stock | 7,839 | 67,908 |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from the private placement | $ 20,400,000 |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds from issuance of private placement | 19,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Conversion of stock, shares converted |  | 75,746 |  |  |  |  |  |  |  |  |  |  |
Sale of stock, shares |  | 4,985,610 |  |  |  |  |  |  |  |  |  |  |
Commissions paid | $ 1,400,000 |  |  |  |  |  |  |  |  |  |  |  |
Shelf Registration Statement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance and sale of equity |  |  |  |  | $ 100,000,000 |  |  |  |  |  |  |  |
ATM |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued |  |  |  |  |  |  |  | 8,950 |  |  |  |  |
Net proceeds |  |  |  |  |  |  |  | $ 51,000 |  |  |  |  |
Settlement Fees |  |  |  |  |  |  |  | 500 |  |  |  |  |
Commissions paid |  |  |  |  |  |  |  | $ 1,500 |  |  | $ 13,000 |  |
Remaining amount of available for sale |  |  |  |  |  |  |  |  |  |  | 17,000,000 |  |
Issuance and sale of equity |  |  |  |  |  |  |  |  |  |  | $ 17,300,000 |  |
Amended and Restated Certificate of Incorporation |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, shares authorized |  |  |  |  |  |  |  | 500,000,000 |  |  | 500,000,000 |  |
Preferred stock, shares authorized |  |  |  |  |  |  |  | 10,000,000 |  |  | 10,000,000 |  |
Common stock par value |  |  |  |  |  |  |  | $ 0.0001 |  |  | $ 0.0001 |  |
Preferred stock, par value |  |  |  |  |  |  |  | $ 0.0001 |  |  | $ 0.0001 |  |
Chief Financial Officer |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  | $ 0.19 |  |  |  |  |  |
Stock and warrants issued during period shares common stock and warrants |  |  |  | 10,000 |  |  | 400,000 |  |  |  |  |  |
Warrant liability fair value |  |  |  | $ 20,000 |  |  | $ 120,000 |  |  |  |  |  |
Expected term (years) |  |  |  | 12 months |  |  | 10 years |  |  |  |  |  |
Risk free interest rate |  |  |  | 4.42% |  |  | 0.96% |  |  |  |  |  |
Expected volatility |  |  |  | 89.00% |  |  | 80.00% |  |  |  |  |  |
Expected dividend yield |  |  |  | 0.00% |  |  | 0.00% |  |  |  |  |  |
General and administrative |  |  |  |  |  |  |  | $ 3,000 |  |  | $ 3,000 |  |
Vesting period |  |  |  |  |  |  | 24 months |  |  |  |  |  |
Warrant term |  |  |  |  |  |  | 10 years |  |  |  |  |  |
Officers and Directors |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Stock and warrants issued during period shares common stock and warrants |  |  |  |  |  | 496,970 |  |  |  |  |  |  |
Warrant liability fair value |  |  |  |  |  | $ 125,000 |  |  |  |  |  |  |
Expected term (years) |  |  |  |  |  | 10 years |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  | 4.10% |  |  |  |  |  |  |
Expected volatility |  |  |  |  |  | 82.00% |  |  |  |  |  |  |
Expected dividend yield |  |  |  |  |  | 0.00% |  |  |  |  |  |  |
General and administrative |  |  |  |  |  |  |  | $ 2,000 |  | 14,000 | $ 4,000 | $ 28,000 |
Warrant term |  |  |  |  |  | 10 years |  |  |  |  |  |  |
Directors, Employees or Consultants | 2024 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  |  | $ 4.3915 |  |  | $ 4.3915 |  |
Maximum |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  | 3.56% |
Expected volatility |  |  |  |  |  |  |  |  |  |  |  | 76.00% |
Maximum | Officers and Directors |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  | 48 months |  |  |  |  |  |  |
Minimum |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  | 3.50% |
Expected volatility |  |  |  |  |  |  |  |  |  |  |  | 75.00% |
Minimum | Officers and Directors |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  | 12 months |  |  |  |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued |  |  |  |  |  |  |  | 8,950 |  |  | 101,522 |  |
Net proceeds |  |  |  |  |  |  |  |  |  |  | $ 319,000 |  |
Fair value of common stock |  | $ 8.5 |  |  |  |  |  |  |  |  |  |  |
Common stock, shares issued |  |  | 1,571,433 |  |  |  |  |  |  |  |  |  |
Common Warrants | 2024 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  |  | $ 3.827 |  |  | $ 3.827 |  |
Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrant liability |  |  |  |  |  |  |  | $ 0 |  | 0 | $ 0 | $ 796,000 |
Pre Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  |  | $ 0.0001 |  |  | $ 0.0001 |  |
Warrant liability fair value |  |  |  |  |  |  |  | $ 500,000 |  |  | $ 500,000 |  |
Pre Funded Warrants | 2024 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  |  | $ 3.8269 |  |  | $ 3.8269 |  |
Number of warrants converted to common stock |  | 306,506 |  |  |  |  |  |  |  |  |  |  |
Decrease in warrant exercise price |  |  |  |  |  |  |  |  |  |  | 0.0001 |  |
Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  |  | $ 0.0001 |  |  | $ 0.0001 |  |
Warrant liability fair value |  |  |  |  |  |  |  | $ 100,000 |  |  | $ 100,000 |  |
Tranche A Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  |  | $ 5.36 |  |  | $ 5.36 |  |
Fair value of warrant liability |  |  |  |  |  |  |  | $ 1,200,000 |  |  | $ 3,900,000 |  |
Warrants expiration date |  |  |  |  |  |  |  | Jul. 27, 2024 |  |  | Jul. 27, 2024 |  |
Warrant liability fair value |  |  |  |  |  |  |  | $ 4,100,000 |  |  | $ 4,100,000 |  |
Fair value of warrants |  |  |  |  |  |  |  | $ 200,000 |  |  | $ 200,000 |  |
Expected term (years) |  |  |  |  |  |  |  |  |  |  | 11 months 8 days |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  | 4.90% |  |
Expected volatility |  |  |  |  |  |  |  |  |  |  | 100.00% |  |
Expected dividend yield |  |  |  |  |  |  |  |  |  |  | 0.00% |  |
Tranche A Common Warrants | 2024 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants converted to common stock |  | 2,646,058 |  |  |  |  |  |  |  |  |  |  |
Tranche B Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  |  | $ 7.15 |  |  | $ 7.15 |  |
Fair value of warrant liability |  |  |  |  |  |  |  | $ 1,100,000 |  |  | $ 4,000,000 |  |
Warrant liability fair value |  |  |  |  |  |  |  | 7,100,000 |  |  | 7,100,000 |  |
Fair value of warrants |  |  |  |  |  |  |  | 3,100,000 |  |  | $ 3,100,000 |  |
Expected term (years) |  |  |  |  |  |  |  |  |  |  | 1 year 8 months 8 days |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  | 4.50% |  |
Expected volatility |  |  |  |  |  |  |  |  | 100.00% |  |  |  |
Expected dividend yield |  |  |  |  |  |  |  |  |  |  | 0.00% |  |
Tranche A and Tranche B Common Warrants |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock, shares |  | 2,646,058 |  |  |  |  |  |  |  |  |  |  |
Warrants | Chief Financial Officer |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
General and administrative |  |  |  |  |  |  |  | $ 0 |  | $ 13,000 | $ 0 | $ 25,000 |
Pre Merger CalciMedica | 2023 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of stock, shares converted |  |  | 20,706,997 |  |  |  |  |  |  |  |  |  |
Pre Merger CalciMedica | Calcimedica Preferred Stock | 2023 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of stock, shares converted |  |  | 84,820,880 |  |  |  |  |  |  |  |  |  |
Post Merger CalciMedica | 2023 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of Stock, Shares Issued |  |  | 596,363 |  |  |  |  |  |  |  |  |  |
Post Merger CalciMedica | Calcimedica Preferred Stock | 2023 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of Stock, Shares Issued |  |  | 84,820,880 |  |  |  |  |  |  |  |  |  |
Post Merger CalciMedica | Calcimedica Common Stock | 2023 Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of Stock, Shares Issued |  |  | 2,442,852 |  |  |  |  |  |  |  |  |  |
Post Merger Transaction | Chief Financial Officer |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  |  |  | $ 6.6 |  |  | $ 6.6 |  |
Number of warrants converted to common stock |  |  |  |  |  |  | 11,520 |  |  |  |  |  |
Post Merger Transaction | Officers and Directors |  |  |  |  |  |  |  |  |  |  |  |  |
Temporary Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants per share |  |  |  |  |  | $ 10.42 |  |  |  |  |  |  |
Number of warrants converted to common stock |  |  |  |  |  | 14,313 |  |  |  |  |  |  |

X
- Definition Gross proceeds from the private placement + References No definition available. + Details
Name: | ck0001534133_GrossProceedsFromThePrivatePlacement
Namespace Prefix: | ck0001534133_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net proceeds from issuance of private placement. + References No definition available. + Details
Name: | ck0001534133_NetProceedsFromIssuanceOfPrivatePlacement
Namespace Prefix: | ck0001534133_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sale of stock remaining sales amount. + References No definition available. + Details
Name: | ck0001534133_SaleOfStockRemainingSalesAmount
Namespace Prefix: | ck0001534133_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Settlement fees. + References No definition available. + Details
Name: | ck0001534133_SettlementFees
Namespace Prefix: | ck0001534133_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Shelf registration statement avaliable for sale. + References No definition available. + Details
Name: | ck0001534133_ShelfRegistrationStatementAvaliableForSale
Namespace Prefix: | ck0001534133_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Stock and warrants issued during period shares common stock and warrants. + References No definition available. + Details
Name: | ck0001534133_StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants
Namespace Prefix: | ck0001534133_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 + Details
Name: | us-gaap_CommonStockSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_ConversionOfStockDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_ConversionOfStockSharesConverted1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_ConversionOfStockSharesIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of the entity's equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_EquityFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 25 -Paragraph 13 -SubTopic 10 -Topic 480 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair value of asset after deduction of liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueNetAssetLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 + Details
Name: | us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 + Details
Name: | us-gaap_PreferredStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 + Details
Name: | us-gaap_PreferredStockSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The risk-free interest rate assumption that is used in valuing an option on its own shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_TemporaryEquityLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_WarrantExercisePriceDecrease
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_TwoThousandAndTwentyFourPrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_ShelfRegistrationStatementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=ck0001534133_AtTheMarketOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CumulativeEffectPeriodOfAdoptionAxis=ck0001534133_AmendedAndRestatedCertificateOfIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=ck0001534133_OfficersAndDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=ck0001534133_DirectorsEmployeesOrConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ck0001534133_CommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ck0001534133_PreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ck0001534133_PlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheACommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheBCommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ck0001534133_TrancheAAndTrancheBCommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=ck0001534133_PreMergerCalcimedicaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=ck0001534133_CalcimedicaPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=ck0001534133_PostMergerCalcimedicaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=ck0001534133_CalcimedicaCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=ck0001534133_PostMergerTransactionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |